Medium supplementation can influence the human ovarian cells in vitro

被引:6
作者
Dadashzadeh, Arezoo [1 ]
Moghassemi, Saeid [1 ]
Grubliauskaite, Monika [2 ]
Vlieghe, Hanne [1 ]
Brusa, Davide [3 ]
Amorim, Christiani A. [1 ]
机构
[1] Catholic Univ Louvain, Inst Rech Experimentale & Clin, Pole Rech Physiopathol Reprod, Ave Hippocrate 55,Bte B1 55-03, B-1200 Brussels, Belgium
[2] Natl Canc Inst, Dept Biobank, LT-08660 Vilnius, Lithuania
[3] Catholic Univ Louvain, Inst Rech Experimentale & Clin, CytoFlux Flow Cytometry & Cell Sorting Platform, B-1200 Brussels, Belgium
关键词
Cellcharacterization; Ovary; Fetalbovine serum; Humanserum albumin; Plateletlysate; KnockOutserum; FETAL BOVINE SERUM; MESENCHYMAL STEM-CELLS; REPLACEMENT MEDIUM; ENDOTHELIAL-CELLS; EXPRESSION; ALBUMIN; SURFACE; BLOOD; DIFFERENTIATION; FIBROBLASTS;
D O I
10.1186/s13048-022-01081-2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Cells are an essential part of the triple principles of tissue engineering and a crucial component of the engineered ovary as they can induce angiogenesis, synthesize extracellular matrix and influence follicle development. Here, we hypothesize that by changing the medium supplementation, we can obtain different cell populations isolated from the human ovary to use in the engineered ovary. To this end, we have in vitro cultured cells isolated from the menopausal ovarian cortex using different additives: KnockOut serum replacement (KO), fetal bovine serum (FBS), human serum albumin (HSA), and platelet lysate (PL). Results: Our results showed that most cells soon after isolation (pre-culture, control) and cells in KO and FBS groups were CD31- CD34- (D0: vs. CD31-CD34+, CD31 + CD34+, and CD31 + CD34- p < 0.0001; KO: vs. CD31-CD34+, CD31 + CD34+, and CD31 + CD34- p < 0.0001; FBS: vs. CD31-CD34+ and CD31 + CD34+ p < 0.001, and vs. CD31 + CD34- p < 0.01). Moreover, a deeper analysis of the CD31-CD34- population demonstrated a significant augmentation (more than 86%) of the CD73+ and CD90+ cells (possibly fibroblasts, mesenchymal stem cells, or pericytes) in KO- and FBS-based media compared to the control (around 16%; p < 0.001). Still, in the CD31-CD34- population, we found a higher proportion (60%) of CD90+ and PDPN+ cells (fibroblast-like cells) compared to the control (around 7%; vs PL and KO p < 0.01 and vs FBS p < 0.001). Additionally, around 70% of cells in KO- and FBS-based media were positive for CD105 and CD146, which may indicate an increase in the number of pericytes in these media compared to a low percentage (4%) in the control group (vs KO and FBS p < 0.001). On the other hand, we remarked a significant decrease of CD31- CD34+ cells after in vitro culture using all different medium additives (HSA vs D0 p < 0.001, PL, KO, and FBS vs D0 P < 0.01). We also observed a significant increase in epithelial cells (CD326+) when the medium was supplemented with KO (vs D0 p < 0.05). Interestingly, HSA and PL showed more lymphatic endothelial cells compared to other groups (CD31 + CD34+: HSA and PL vs KO and FBS p < 0.05; CD31 + CD34 + CD90 + PDPN+: HSA and PL vs D0 p < 0.01). Conclusion: Our results demonstrate that medium additives can influence the cell populations, which serve as building blocks for the engineered tissue. Therefore, according to the final application, different media can be used in vitro to favor different cell types, which will be incorporated into a functional matrix.
引用
收藏
页数:12
相关论文
共 57 条
[11]  
DeLisser H.M., 2006, Encyclopedia of respiratory medicine /, P29, DOI DOI 10.1016/B0-12-370879-6/00008-9
[12]   Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317
[13]   Single-cell reconstruction of follicular remodeling in the human adult ovary [J].
Fan, X. ;
Bialecka, M. ;
Moustakas, I ;
Lam, E. ;
Torrens-Juaneda, V ;
Borggreven, N., V ;
Trouw, L. ;
Louwe, L. A. ;
Pilgram, G. S. K. ;
Mei, H. ;
van der Westerlaken, L. ;
Lopes, S. M. Chuva de Sousa .
NATURE COMMUNICATIONS, 2019, 10 (1)
[14]   Characterization of Mesenchymal Progenitor Cell Populations Directly Derived from Human Dermis [J].
Feisst, Vaughan ;
Brooks, Anna E. S. ;
Chen, Chun-Jen J. ;
Dunbar, P. Rod .
STEM CELLS AND DEVELOPMENT, 2014, 23 (06) :631-642
[15]   Comparative characteristics of endothelial-like cells derived from human adipose mesenchymal stem cells and umbilical cord blood-derived endothelial cells [J].
Gaafar, Taghrid M. ;
Abdel Rahman, Hala A. ;
Attia, Wael ;
Hamza, Hala S. ;
Brockmeier, Konrad ;
El Hawary, Rabab E. .
CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 14 (02) :177-184
[16]   Evaluation of a new freezing protocol containing 20% dimethyl sulphoxide concentration to cryopreserve human ovarian tissue [J].
Gallardo, Miguel ;
Paulini, Fernanda ;
Corral, Ariadna ;
Balcerzyk, Marcin ;
Lucci, Carolina M. ;
Ambroise, Jerome ;
Merola, Marta ;
Fernandez-maza, Laura ;
Risco, Ramon ;
Dolmans, Marie-Madeleine ;
Amorim, Christiani A. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2018, 37 (06) :653-665
[17]   Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies [J].
Geevarghese, Anita ;
Herman, Ira M. .
TRANSLATIONAL RESEARCH, 2014, 163 (04) :296-306
[18]   Cells for tissue engineering [J].
Heath, CA .
TRENDS IN BIOTECHNOLOGY, 2000, 18 (01) :17-19
[19]   MAINTENANCE OF TRANSPLANTATION POTENTIAL IN EX-VIVO EXPANDED CD34(+)-SELECTED HUMAN PERIPHERAL-BLOOD PROGENITOR CELLS [J].
HENSCHLER, R ;
BRUGGER, W ;
LUFT, T ;
FREY, T ;
MERTELSMANN, R ;
KANZ, L .
BLOOD, 1994, 84 (09) :2898-2903
[20]  
Herndon JM., 2017, Primer on Cerebrovascular Diseases Second Edition, P51, DOI DOI 10.1016/B978-0-12-803058-5.00009-6